Control Bionics Limited (CBL.AX)
AUD 0.06
(-1.69%)
AUD 0.06
(-1.69%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 5.12 Million AUD | -5.67% |
| 2023 | 5.43 Million AUD | 24.08% |
| 2022 | 4.38 Million AUD | 11.49% |
| 2021 | 3.92 Million AUD | 26.77% |
| 2020 | 3.09 Million AUD | 296.58% |
| 2019 | 781.44 Thousand AUD | -2.98% |
| 2018 | 805.41 Thousand AUD | -99.75% |
| 2017 | 323.69 Million NZD | 30.36% |
| 2016 | 248.31 Million NZD | 0.0% |
| 2015 | - NZD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 1.19 Million AUD | 0.0% |
| 2024 Q3 | 1.19 Million AUD | -59.74% |
| 2024 FY | 5.35 Million AUD | -1.55% |
| 2024 Q1 | 1.58 Million AUD | -42.06% |
| 2024 Q2 | 2.96 Million AUD | 86.49% |
| 2023 Q1 | 1.65 Million AUD | -21.62% |
| 2023 FY | 5.43 Million AUD | 24.08% |
| 2023 Q2 | 2.89 Million AUD | 74.93% |
| 2023 Q4 | 2.74 Million AUD | 93.01% |
| 2023 Q3 | 1.42 Million AUD | -50.97% |
| 2022 FY | 4.38 Million AUD | 11.49% |
| 2022 Q4 | 2.11 Million AUD | 0.0% |
| 2021 FY | 3.92 Million AUD | 26.77% |
| 2020 FY | 3.09 Million AUD | 296.58% |
| 2019 FY | 781.44 Thousand AUD | -2.98% |
| 2018 FY | 805.41 Thousand AUD | -99.75% |
| 2017 FY | 323.69 Million NZD | 30.36% |
| 2016 FY | 248.31 Million NZD | 0.0% |
| 2016 Q4 | 80.92 Million NZD | 0.0% |
| 2016 Q3 | 80.92 Million NZD | 0.0% |
| 2016 Q2 | 80.92 Million NZD | 30.36% |
| 2016 Q1 | 62.07 Million NZD | 0.0% |
| 2015 Q2 | 62.07 Million NZD | 0.0% |
| 2015 Q4 | 62.07 Million NZD | 0.0% |
| 2015 Q3 | 62.07 Million NZD | 0.0% |
| 2015 FY | - NZD | 0.0% |
| 2015 Q1 | - NZD | 0.0% |
| 2014 Q2 | - NZD | 0.0% |
| 2014 Q4 | - NZD | 0.0% |
| 2014 Q3 | - NZD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -36.562% |
| Adherium Limited | 840.98 Thousand AUD | -509.632% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 91.908% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -25.458% |
| Anteris Technologies Ltd | 4.11 Million AUD | -24.709% |
| CardieX Limited | 10.9 Million AUD | 52.989% |
| Compumedics Limited | 49.71 Million AUD | 89.688% |
| Cochlear Limited | 2.25 Billion AUD | 99.773% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 67.39% |
| Cyclopharm Limited | 27.13 Million AUD | 81.109% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 54.302% |
| Nova Eye Medical Limited | 23.32 Million AUD | 78.02% |
| HeraMED Limited | 402.89 Thousand AUD | -1172.508% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -732.873% |
| ImpediMed Limited | 10.31 Million AUD | 50.316% |
| InhaleRx Limited | 1.2 Million AUD | -325.806% |
| LBT Innovations Limited | 1.25 Million AUD | -308.192% |
| Micro-X Limited | 15.22 Million AUD | 66.319% |
| Neurotech International Limited | 1963.00 AUD | -261076.617% |
| OncoSil Medical Limited | 1.56 Million AUD | -227.517% |
| PolyNovo Limited | 103.19 Million AUD | 95.032% |
| Respiri Limited | 456.91 Thousand AUD | -1022.07% |
| SomnoMed Limited | 91.65 Million AUD | 94.406% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 22.704% |
| Uscom Limited | 3.72 Million AUD | -37.567% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 40.866% |